Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: So, if Philips owns 19.9%
Yes, I read that too.  So how is it possible that (Philips), which owns only 19.9% of (NXP),  signs a license agreement with us without their partners (KKR et al) owning 80.1% of NXP having to sign too?
Share
New Message
Please login to post a reply